These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 4144989)
1. The importance of dosage in antipsychotic drug administration--a review of dose-response studies. Gardos G; Cole JO Psychopharmacologia; 1973; 29(3):221-30. PubMed ID: 4144989 [No Abstract] [Full Text] [Related]
2. Recent developments in the drug treatment of schizophrenia. Davis JM Am J Psychiatry; 1976 Feb; 133(2):208-14. PubMed ID: 766652 [TBL] [Abstract][Full Text] [Related]
3. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients. Spiegel DE; Keith-Spiegel P J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760 [No Abstract] [Full Text] [Related]
4. Clinical studies with propericiazine (R.P. 8909). St Jean A; Sterlin C; Noe W; Ban TA Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004 [No Abstract] [Full Text] [Related]
5. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine). Platz AR; Klett CJ; Caffey EM Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216 [No Abstract] [Full Text] [Related]
6. Single daily doses of neuroleptic drugs. Brophy JJ Dis Nerv Syst; 1969 Feb; 30(2):120-3. PubMed ID: 5774571 [No Abstract] [Full Text] [Related]
7. Triiodothyronine and phenothiazines in schizophrenia. Wolpert A; Yaryura-Tobias JA; White L; Merlis S Dis Nerv Syst; 1969 Jul; 30(7):487-9. PubMed ID: 5810556 [No Abstract] [Full Text] [Related]
9. High dose trifluoperazine therapy in chronic schizophrenia. Prien RF; Levine J; Cole JO Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559 [No Abstract] [Full Text] [Related]
10. High doses of trifluperazine and tardive dyskinesia. Crane GE Arch Neurol; 1970 Feb; 22(2):176-80. PubMed ID: 4902773 [No Abstract] [Full Text] [Related]
11. Psychological effects of single-dose antipsychotic medication. Serafetinides EA; Clark ML Biol Psychiatry; 1973 Dec; 7(3):263-7. PubMed ID: 4586833 [No Abstract] [Full Text] [Related]
12. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation. DeWolfe AS; Barrell RP; London L; Spaner FE Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862 [No Abstract] [Full Text] [Related]
13. Quide vs. Mellaril in chronic schizophrenic patients. Gallant DM; Bishop MP Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558 [No Abstract] [Full Text] [Related]
14. [Delayed-action neuroleptics. Indications and technic of use]. Gayral L Sem Ther; 1968 Dec; 44(10):669-71. PubMed ID: 4387604 [No Abstract] [Full Text] [Related]
15. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics. Hunt PV Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294 [No Abstract] [Full Text] [Related]
16. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A; Güclü B; Kulkarni AS Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
18. A controlled study of mesoridazine: an effective treatment for schizophrenia. McIndoo MV South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612 [No Abstract] [Full Text] [Related]